The Role of Tissue Acquisition in Advancing Community Precision Oncology
Community cancer centers are fast becoming sites for biomarker testing and precision medicine. As clinical research becomes a larger part of community cancer center operations, strengthening tissue collection procedures and considering the establishment of biospecimen repositories are critical concerns.
Join us for a live discussion on Thursday, December 17, about key issues in high integrity tissue acquisition facing community cancer programs. Expert panelists will share their perspectives and best practices on how much, when, and from which sites tissue and other biopsy samples should be collected, how acquisition and storage changes depending on the purpose of collection, and more.
- Lawrence D. Wagman, MD, Surgical Oncologist, Medical Director, City of Hope National Medical Center
- Michelle Shiller, DO, AP/CP, MGP, Co-Medical Director of Genetics, Baylor Sammons Cancer Center; Staff Pathologist, Baylor University Medical Center
For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the webcast.
This webcast is part of the 2020-2021 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research. This important work includes a monthly research newsletter, a series of webcasts on research-related topics of interest, blog posts, and additional resources.
You must have an ACCC or state society account to register for this webinar.
If You DO NOT Have an Account:
- To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
- ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.
- Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.
- Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
- The green box in the upper right corner of this page will indicate “You are registered!” for this course!
If You Have an ACCC Account:
- Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
- You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course!
PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!
For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.
Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact firstname.lastname@example.org.
Lawrence Wagman, MD, FACS, FPCS (hon)
Surgical Oncologist, Medical Director, City of Hope National Medical Center
Michelle Shiller, DO, AP/CP, MGP
Co-Medical Director of Genetics, Baylor Sammons Cancer Center; Staff Pathologist, Baylor University Medical Center
Dr. Michelle Shiller, DO, AP/CP, MGP, is board certified in Anatomic, Clinical, and Molecular Genetic Pathology following completion of residency at Baylor University Medical Center in Dallas, Texas and fellowship at The Mayo Clinic in Rochester, Minnesota. Upon completion of training, Dr. Shiller established practice with Pathologists Biomedical Laboratories in Dallas, Texas, who services the majority of the DFW metroplex Baylor Scott and White Hospitals. As a result of her experience, she has served on multiple committees considering testing implementation and utilization. Dr. Shiller serves on the Quality Committee for the Baylor Sammons Cancer Center, and as Assistant Medical Director for Cancer Genetics, primarily focusing on germline cancer predisposition, as well as Co-Assistant Medical Director for the Division of Molecular Medicine and Pathology. Finally, within the Baylor Scott and White system, Dr. Shiller has also served on the Baylor Medical Board.
As a result of the emerging field of molecular pathology, Dr. Shiller has provided many educational forums to empower providers and break down barriers to implementation. This has led to Dr. Shiller securing the opportunity and embracing her passion for educating individuals at a larger scale, through the support and encouragement of many pharmaceutical companies in the form of speaking programs, video recordings, webinars and content development. Consequently, Dr. Shiller has also served on steering committees and advisory boards for multiple entities. Dr. Shiller is an active member of the Association for Molecular Pathology, and also served to develop a consistent dialogue between molecular pathology and oncology, assisting with developing the ASCO-sponsored Molecular Tumor Board. With a patient-centered focus, quality, accuracy, relevance, timeliness, teamwork and conscientious stewardship of the patient specimen are considerations that Dr. Shiller is inspired to bring to reality with the ongoing integration of molecular diagnostics in the field of oncology. She is excited to partner with the Association of Community Cancer Centers on the Board of Trustees to further impact patient care positively with this focus.